PortfoliosLab logoPortfoliosLab logo
NEM vs. INSM
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

NEM vs. INSM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Newmont Corporation (NEM) and Insmed Incorporated (INSM). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, NEM achieves a -0.43% return, which is significantly higher than INSM's -45.89% return. Over the past 10 years, NEM has underperformed INSM with an annualized return of 13.46%, while INSM has yielded a comparatively higher 24.09% annualized return.


NEM

1D
-0.72%
1M
-14.84%
YTD
-0.43%
6M
11.71%
1Y
91.07%
3Y*
36.63%
5Y*
10.33%
10Y*
13.46%

INSM

1D
-0.05%
1M
-7.08%
YTD
-45.89%
6M
-52.09%
1Y
27.91%
3Y*
68.17%
5Y*
27.84%
10Y*
24.09%
*Multi-year figures are annualized to reflect compound growth (CAGR)

NEM vs. INSM - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
NEM
Newmont Corporation
-0.43%172.82%-7.83%-8.76%-20.77%7.40%40.28%30.52%-6.15%10.91%
INSM
Insmed Incorporated
-45.89%152.09%122.78%55.11%-26.65%-18.17%39.41%82.01%-57.92%135.68%

Correlation

The correlation between NEM and INSM is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.20

Correlation (3Y)
Calculated over the trailing 3-year period

0.19

Correlation (5Y)
Calculated over the trailing 5-year period

0.16

Correlation (10Y)
Calculated over the trailing 10-year period

0.10

Correlation (All Time)
Calculated using the full available price history since Jun 2, 2000

0.05

The correlation between NEM and INSM shifts across timeframes, from 0.05 (all time) to 0.20 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

EPS

NEM:

$6.34

INSM:

-$5.71

PS Ratio

NEM:

4.77

INSM:

23.84

Total Revenue (TTM)

NEM:

$17.23B

INSM:

$819.56M

Gross Profit (TTM)

NEM:

$8.97B

INSM:

$668.55M

EBITDA (TTM)

NEM:

$13.78B

INSM:

-$1.14B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NEM vs. INSM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NEM
NEM Risk / Return Rank: 8585
Overall Rank
NEM Sharpe Ratio Rank: 8888
Sharpe Ratio Rank
NEM Sortino Ratio Rank: 8080
Sortino Ratio Rank
NEM Omega Ratio Rank: 8282
Omega Ratio Rank
NEM Calmar Ratio Rank: 8686
Calmar Ratio Rank
NEM Martin Ratio Rank: 8686
Martin Ratio Rank

INSM
INSM Risk / Return Rank: 5757
Overall Rank
INSM Sharpe Ratio Rank: 5858
Sharpe Ratio Rank
INSM Sortino Ratio Rank: 5757
Sortino Ratio Rank
INSM Omega Ratio Rank: 6262
Omega Ratio Rank
INSM Calmar Ratio Rank: 5454
Calmar Ratio Rank
INSM Martin Ratio Rank: 5555
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NEM vs. INSM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Newmont Corporation (NEM) and Insmed Incorporated (INSM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


NEMINSMDifference
Sharpe ratioReturn per unit of total volatility

+1.48

Sortino ratioReturn per unit of downside risk

+1.17

Omega ratioGain probability vs. loss probability

1.32

1.17

+0.15

Calmar ratioReturn relative to maximum drawdown

3.36

0.51

+2.85

Martin ratioReturn relative to average drawdown

8.94

1.23

+7.71

NEM vs. INSM - Sharpe Ratio Comparison

The current NEM Sharpe Ratio is 1.96, which is higher than the INSM Sharpe Ratio of 0.47. The chart below compares the historical Sharpe Ratios of NEM and INSM, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


NEMINSMDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.96

0.47

+1.48

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.27

0.38

-0.11

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.38

0.31

+0.07

Sharpe Ratio (All Time)

Calculated using the full available price history

0.12

-0.02

+0.15

Drawdowns

NEM vs. INSM - Drawdown Comparison

The maximum NEM drawdown since its inception was -81.30%, smaller than the maximum INSM drawdown of -98.65%. Use the drawdown chart below to compare losses from any high point for NEM and INSM.


Loading charts...

Drawdown Indicators


NEMINSMDifference

Max Drawdown

Largest peak-to-trough decline

-81.30%

-98.65%

+17.35%

Max Drawdown (1Y)

Largest decline over 1 year

-27.25%

-55.46%

+28.21%

Max Drawdown (3Y)

Largest decline over 3 years

-36.57%

-55.46%

+18.89%

Max Drawdown (5Y)

Largest decline over 5 years

-62.40%

-55.46%

-6.94%

Max Drawdown (10Y)

Largest decline over 10 years

-62.40%

-64.84%

+2.44%

Current Drawdown

Current decline from peak

-24.65%

-55.46%

+30.81%

Average Drawdown

Average peak-to-trough decline

-41.38%

-86.11%

+44.73%

Ulcer Index

Depth and duration of drawdowns from previous peaks

10.22%

22.66%

-12.44%

Volatility

NEM vs. INSM - Volatility Comparison

The current volatility for Newmont Corporation (NEM) is 14.19%, while Insmed Incorporated (INSM) has a volatility of 18.58%. This indicates that NEM experiences smaller price fluctuations and is considered to be less risky than INSM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


NEMINSMDifference

Volatility (1M)

Calculated over the trailing 1-month period

14.19%

18.58%

-4.39%

Volatility (6M)

Calculated over the trailing 6-month period

36.93%

45.00%

-8.07%

Volatility (1Y)

Calculated over the trailing 1-year period

46.87%

59.24%

-12.37%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

37.83%

72.76%

-34.93%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

35.59%

78.47%

-42.88%

Dividends

NEM vs. INSM - Dividend Comparison

NEM's dividend yield for the trailing twelve months is around 1.03%, while INSM has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
INSM
Insmed Incorporated
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
NEM
Newmont Corporation
1.03%1.00%2.69%3.87%4.66%3.55%1.74%3.31%1.62%0.67%0.37%0.56%

Financials

NEM vs. INSM - Financials Comparison

This section allows you to compare key financial metrics between Newmont Corporation and Insmed Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B5.00B6.00B7.00B202220232024202520260
305.96M
(NEM) Total Revenue
(INSM) Total Revenue
Values in USD except per share items

Frequently Asked Questions


NEM and INSM have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

INSM has higher volatility (18.58%) compared to NEM (14.19%). In terms of maximum drawdown, NEM dropped -81.30% vs INSM's -98.65%.

NEM currently has the higher Sharpe Ratio (1.96 vs 0.47), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for NEM and INSM

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer